• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡公众对肠道微生物群和粪便微生物群移植的了解、认知与看法:一项调查研究

Public knowledge, awareness and perception of gut microbiome and faecal microbiota transplantation in Singapore: a survey study.

作者信息

Lim Lydia Wan Zhen, Toh Kai Yee, Cook Alex Richard, Lee Jonathan Wei Jie, Lim Jeremy Fung Yen

机构信息

AMILI Pte Ltd, Singapore.

Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

出版信息

Singapore Med J. 2025 Aug 1;66(8):439-448. doi: 10.4103/singaporemedj.SMJ-2024-076. Epub 2025 Jun 6.

DOI:10.4103/singaporemedj.SMJ-2024-076
PMID:40472289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12404425/
Abstract

INTRODUCTION

Despite the exponential increase in microbiome research, knowledge and beliefs about the gut microbiome and faecal microbiota transplantation (FMT) remain unclear. The aim of this study was to identify the extent of knowledge, awareness and perception among the general public regarding the gut microbiome and FMT.

METHODS

An online questionnaire on knowledge and beliefs about the gut microbiome and FMT was administered to 1831 participants. Data analysis software was used to generate descriptive statistics and explore associations between knowledge and sociodemographic variables.

RESULTS

Even though only 33% of participants had heard of the gut microbiome, more than 92% had consumed probiotic drinks or supplements. While 85% had not heard of the FMT procedure, 72% of respondents would consider having FMT to treat Clostridioides difficile infection (CDI). Willingness to receive FMT depended mainly on recommendation from healthcare providers (77%). Knowledge and awareness regarding the gut microbiome and FMT were relatively low, despite most participants having prior gut health-related behaviours.

CONCLUSION

This study identified the public's perceptions of FMT and the potential barriers to its uptake. Insights from the study highlight the need for health education to enhance acceptance of FMT and the importance of using information supported by medical professionals to immunise the public against poorly validated science.

摘要

引言

尽管微生物组研究呈指数级增长,但关于肠道微生物组和粪便微生物群移植(FMT)的知识和观念仍不明确。本研究的目的是确定普通公众对肠道微生物组和FMT的了解程度、认知度和看法。

方法

对1831名参与者进行了一项关于肠道微生物组和FMT的知识与观念的在线问卷调查。使用数据分析软件生成描述性统计数据,并探讨知识与社会人口统计学变量之间的关联。

结果

尽管只有33%的参与者听说过肠道微生物组,但超过92%的人食用过益生菌饮料或补充剂。虽然85%的人没有听说过FMT程序,但72%的受访者会考虑接受FMT来治疗艰难梭菌感染(CDI)。接受FMT的意愿主要取决于医疗保健提供者的建议(77%)。尽管大多数参与者之前有与肠道健康相关的行为,但对肠道微生物组和FMT的知识和认知度相对较低。

结论

本研究确定了公众对FMT的看法及其采用的潜在障碍。该研究的见解强调了健康教育以提高对FMT的接受度的必要性,以及利用医学专业人员支持的信息使公众免受未经充分验证的科学影响的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/0e7c72bd0419/SMJ-66-439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/22b1534ebf98/SMJ-66-439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/e6347fe2d48c/SMJ-66-439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/021beb0cf623/SMJ-66-439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/0fa77d0303e2/SMJ-66-439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/0e7c72bd0419/SMJ-66-439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/22b1534ebf98/SMJ-66-439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/e6347fe2d48c/SMJ-66-439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/021beb0cf623/SMJ-66-439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/0fa77d0303e2/SMJ-66-439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/12404425/0e7c72bd0419/SMJ-66-439-g005.jpg

相似文献

1
Public knowledge, awareness and perception of gut microbiome and faecal microbiota transplantation in Singapore: a survey study.新加坡公众对肠道微生物群和粪便微生物群移植的了解、认知与看法:一项调查研究
Singapore Med J. 2025 Aug 1;66(8):439-448. doi: 10.4103/singaporemedj.SMJ-2024-076. Epub 2025 Jun 6.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Host origin of microbiota drives functional recovery and clearance in mice.微生物群的宿主来源驱动小鼠的功能恢复和清除。
mBio. 2025 Jun 2:e0110825. doi: 10.1128/mbio.01108-25.
4
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.基于肠道微生物群的干预措施用于管理19岁及以下儿童和青少年的肥胖问题。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
5
Faecal microbiota transplantation for recurrent Clostridiodes difficile infection & its global regulatory landscape.粪菌移植治疗复发性艰难梭菌感染及其全球监管格局。
Indian J Med Res. 2025 Feb;161(2):113-119. doi: 10.25259/IJMR_818_2024.
6
Fecal Microbiota Transplantation (FMT) in Clostridium difficile Infection: A Paradigm Shift in Gastrointestinal Microbiome Modulation.艰难梭菌感染中的粪便微生物群移植(FMT):胃肠道微生物组调节的范式转变
Cureus. 2025 May 29;17(5):e85054. doi: 10.7759/cureus.85054. eCollection 2025 May.
7
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis.肠道炎症与微生物群调节影响耳蜗功能:肠道-耳轴的新见解
Cell Commun Signal. 2025 Jul 26;23(1):357. doi: 10.1186/s12964-025-02338-1.
8
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.系统评价与荟萃分析:粪便微生物群移植治疗复发性和难治性艰难梭菌感染的疗效
Aliment Pharmacol Ther. 2017 Sep;46(5):479-493. doi: 10.1111/apt.14201. Epub 2017 Jul 14.
9
Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.粪便微生物移植治疗艰难梭菌感染:系统评价。
Ann Intern Med. 2015 May 5;162(9):630-8. doi: 10.7326/M14-2693.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

引用本文的文献

1
Recent advances in gastroenterology.胃肠病学的最新进展。
Singapore Med J. 2025 Aug 1;66(8):412. doi: 10.4103/singaporemedj.SMJ-2025-170. Epub 2025 Aug 20.

本文引用的文献

1
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.AGA 临床实践指南:基于粪便微生物群的疗法治疗特定胃肠道疾病。
Gastroenterology. 2024 Mar;166(3):409-434. doi: 10.1053/j.gastro.2024.01.008.
2
Hard work, long hours, and Singaporean young adults' health-A qualitative study.努力工作、长时间工作与新加坡青年的健康:一项定性研究。
Front Public Health. 2023 Jun 12;11:1082581. doi: 10.3389/fpubh.2023.1082581. eCollection 2023.
3
Host-diet-gut microbiome interactions influence human energy balance: a randomized clinical trial.
宿主-饮食-肠道微生物组相互作用影响人体能量平衡:一项随机临床试验。
Nat Commun. 2023 May 31;14(1):3161. doi: 10.1038/s41467-023-38778-x.
4
Roles of the gut microbiome in weight management.肠道微生物组在体重管理中的作用。
Nat Rev Microbiol. 2023 Aug;21(8):535-550. doi: 10.1038/s41579-023-00888-0. Epub 2023 May 3.
5
Current Clinical Landscape and Global Potential of Bacteriophage Therapy.噬菌体疗法的当前临床现状和全球潜力。
Viruses. 2023 Apr 21;15(4):1020. doi: 10.3390/v15041020.
6
A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.肠道微生物群衍生代谢物在肿瘤进展和癌症治疗中的研究进展
Adv Sci (Weinh). 2023 May;10(15):e2207366. doi: 10.1002/advs.202207366. Epub 2023 Mar 23.
7
Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.粪便微生物群移植治疗重度抑郁症的可行性、可接受性和安全性:一项先导随机对照试验。
Can J Psychiatry. 2023 May;68(5):315-326. doi: 10.1177/07067437221150508. Epub 2023 Jan 13.
8
The gut microbiome: a core regulator of metabolism.肠道微生物组:代谢的核心调节者。
J Endocrinol. 2023 Jan 19;256(3). doi: 10.1530/JOE-22-0111. Print 2023 Mar 1.
9
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.粪便微生物移植治疗非酒精性脂肪性肝病的随机临床试验。
Front Cell Infect Microbiol. 2022 Jul 4;12:759306. doi: 10.3389/fcimb.2022.759306. eCollection 2022.
10
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.肠道微生物群影响免疫治疗反应:机制和治疗策略。
J Hematol Oncol. 2022 Apr 29;15(1):47. doi: 10.1186/s13045-022-01273-9.